Table 1.
Patient characteristics
| Characteristics | Value or no. of patients |
|---|---|
| Median age at diagnosis | |
| Years (range) | 64 (44–81) |
| Diagnosis | |
| SCLC | 5 |
| NSCLC | 26 |
| Stage | |
| IA | 1 |
| IIA | 3 |
| IIIA | 19 |
| IIIB | 4 |
| IV | 4 |
| Gender | |
| Female | 20 |
| Male | 11 |
| Mean prescribed dose, Gy [RBE] (range) | |
| SCLC | 48 (45–60) |
| NSCLC | 58.2 (50–60) |
| Tumor location | |
| LUL | 8 |
| LLL | 5 |
| RUL | 12 |
| RML | 2 |
| RLL | 4 |
| Median max. tumor motion, cm (range) | 0.6 (0.2–2.1) |
Abbreviations: LLL, left lower lobe; LUL, left upper lobe; NSCLC, nonsmall cell lung cancer; RBE, relative biological effectiveness; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe; SCLC, small cell lung cancer.